gliosarcoma

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)

Suspended
  • Gliosarcoma
  • MGMT-Unmethylated Glioblastoma
  • Ipilimumab
  • +6 more
  • Birmingham, Alabama
  • +285 more
Aug 24, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States

Completed
  • Anaplastic Astrocytoma
  • +3 more
  • 3-Dimensional Conformal Radiation Therapy
  • +3 more
  • Birmingham, Alabama
  • +179 more
Oct 5, 2021

Recurrent Glioblastoma, Recurrent Adult Brain Tumor, Gliosarcoma Trial in United States (HSPPC-96, bevacizumab)

Active, not recruiting
  • Recurrent Glioblastoma
  • +2 more
  • Anchorage, Alaska
  • +416 more
Aug 16, 2021

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,

Completed
  • Glioblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +6 more
  • Mobile, Alabama
  • +329 more
Jul 22, 2019

Glioblastoma Multiforme, Gliosarcoma Trial in United States (ZD6474, temozolomide, Radiation Therapy)

Completed
  • Glioblastoma Multiforme
  • Gliosarcoma
  • Boston, Massachusetts
  • +6 more
Feb 14, 2019

Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma Trial in United States (XL184, temozolomide, Radiation Therapy)

Completed
  • Glioblastoma
  • +2 more
  • Los Angeles, California
  • +7 more
Sep 19, 2014

Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)

Unknown status
  • Malignant Glioma
  • +5 more
  • Birmingham, Alabama
  • +18 more
Apr 1, 2009